Trials / Active Not Recruiting
Active Not RecruitingNCT05308576
A Study to Evaluate the Efficacy and Safety of SCTV01E (a COVID-19 Vaccine) in Population Aged ≥18 Years
A Randomized, Double-blind, Parallel-controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of SCTV01E (Alpha/Beta/Delta/Omicron Variants S-Trimer COVID-19 Vaccine) in Population Aged ≥18 Years
- Status
- Active Not Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 10,000 (estimated)
- Sponsor
- Sinocelltech Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to evaluate the effectiveness of SCTV01E in participants aged ≥18 years.
Detailed description
The study is a randomized, double-blind, placebo-controlled Phase III study. It will evaluate the protective effectiveness and safety of SCTV01E against COVID-19 in participants who were previously received primary series or booster dose of COVID-19 vaccines.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | SCTV01E | D0; intramuscular injection |
| BIOLOGICAL | Placebo | D0; intramuscular injection |
Timeline
- Start date
- 2022-12-26
- Primary completion
- 2023-05-10
- Completion
- 2024-04-01
- First posted
- 2022-04-04
- Last updated
- 2024-04-15
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05308576. Inclusion in this directory is not an endorsement.